Antares Gets Development Payment From Pfizer

EWING, N.J. (AP) — Antares Pharma  (Nasdaq: ATRS) said Tuesday it received a $750,000 milestone payment from its partner Pfizer (NYSE: PFE) .

Antares said the payment was related to the development of an undisclosed consumer health care product. In December 2011 Antares licensed drug delivery technology to Pfizer. Pfizer agreed to give Antares an upfront payment and milestone payments related to development and sales of the product, as well as royalties on any sales made in the first three years after product approval.

Shares of Antares Pharma rose 12 cents, or 2.8 percent, to $4.40 on Tuesday.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.